A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2006
12/20/2006	CN1879646A 复方葛根素注射剂及其制备方法 Compound puerarin injection and its preparation method
12/20/2006	CN1879645A A nano injection formulation of breviscapinum and preparation method thereof
12/20/2006	CN1879640A Use of ginsenosides Rh2, Ck and Rg3 in increasing myocardial contractility
12/20/2006	CN1879639A A nanometer 'Xue Shuan Tong' injection and preparation method thereof
12/20/2006	CN1879638A A nanometer 'Xue Sai Tong' injection and preparation method thereof
12/20/2006	CN1879637A A medicine for treating cardiovascular and cerebrovascular disease
12/20/2006	CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/20/2006	CN1879629A Estrogen replacement therapy
12/20/2006	CN1879622A Milrinone lyophilized powder for injection and preparation method thereof
12/20/2006	CN1879621A Drop pills of amlodipine maleate and preparation method thereof
12/20/2006	CN1879619A Cancer treatment
12/20/2006	CN1879614A A pharmaceutical composition and application thereof in treatment of cardiovascular and cerebrovascular disease
12/20/2006	CN1879611A A lyophilized powder injection of potassium magnesium aspartate and preparation method thereof
12/20/2006	CN1879608A Bioadhesive progressive hydration tablets
12/20/2006	CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1290847C Aza-arylpiperazines
12/20/2006	CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/20/2006	CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
12/20/2006	CN1290825C Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds
12/20/2006	CN1290581C Remedy for hypertension
12/20/2006	CN1290576C Use of thymic hormone beta 15 in preparation of substances for promoting wound healing and generation of blood
12/20/2006	CN1290561C Chinese medicinal composition for treating respiratory illness and digestive illness
12/20/2006	CN1290547C Traditional Chinese medicine for treating and preventing high blood pressure and its preparation technology
12/20/2006	CN1290545C Chinese medicine for treating coronary heart disease, its preparation method and application
12/20/2006	CN1290536C Oral Chinese medicinal composition for treating hypertension
12/20/2006	CN1290530C Fumaiding Chinese medicinal preparation for treating arrhythmia and its preparation method
12/20/2006	CN1290518C Extracting method of propolis effective component and its use
12/20/2006	CN1290517C Preparation method of combination of propolis
12/20/2006	CN1290513C Compound capsule of amino acid and chitosan
12/20/2006	CN1290510C Pharmaceutical composition containing gen-seng total saponin and astragalus root total saponin, its preparing process and application
12/20/2006	CN1290509C New use of saponin compound for treating cardiovascular disease
12/20/2006	CN1290506C Medicinal composition
12/20/2006	CN1290503C Oral liquid of compound anisodine, preparation method and usage
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/20/2006	CN1290491C Medicine for treating acute ischemic cerebral apoplexy and its preparing method
12/20/2006	CN1290441C Rye-red yeast vinegar soft capsule and its preparing method
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	CA2296560C Amino acid derivatives useful to treat stroke
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2246236C Treatment and prevention of adverse effects of reactive oxygen species
12/19/2006	CA2212537C Therapeutic inhibitor of vascular smooth muscle cells
12/19/2006	CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/14/2006	WO2006133045A1 Nanoparticulate benidipine compositions
12/14/2006	WO2006132583A1 Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection
12/14/2006	WO2006132440A1 Solid preparation
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006132295A1 Regulator of aldosterone receptor
12/14/2006	WO2006132223A1 Anti-hypertensive composition
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006132204A1 Transcription factor decoy
12/14/2006	WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
12/14/2006	WO2006132189A1 Screening method for neuronal differentiation inducer
12/14/2006	WO2006132091A1 Novel triglyceride reducing agent
12/14/2006	WO2006131671A2 Protective glasses
12/14/2006	WO2006131586A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
12/14/2006	WO2006131186A1 Oxindoles as kinase inhibitors
12/14/2006	WO2006130901A1 Control of metabolic abnormalities
12/14/2006	WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006	WO2006111757A3 Animal model of vascular smooth muscle cell apoptosis
12/14/2006	WO2006102061A3 Methods of decreasing calcification
12/14/2006	WO2006094246A3 N-arylmethyl benzamide sirtuin modulators
12/14/2006	WO2006082409A3 Tricyclic cytoprotective compounds
12/14/2006	WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
12/14/2006	WO2005003764A3 Assay for detecting atrial and brain natriuretic peptide prohormones
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281820 Lfa-1 inhibitors and use thereof
12/14/2006	US20060281795 Benzinidazole Derivative and Use As AII Receptor Antagonist
12/14/2006	US20060281794 Erg channel openers for the treatment of cardiac arrhythmias
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281715 Phosphates of secondary alcohols
12/14/2006	US20060281706 New phosphonate ester derivatives of drugs such as antivirals cidofovir, adefovir, tenofovir, azidothymidine (AZT), or bisphosphonates such as alendronate, or anticancers such as cytosine arabinoside; side effect reduction, less toxic; antiviral
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060280813 Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses
12/14/2006	US20060280804 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
12/14/2006	US20060280802 Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
12/14/2006	US20060280794 Solid pharmaceutical preparation
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	DE19942897B4 Cycloheptenonderivate, ein Herstellungsverfahren für diese Verbindungen und ihre Verwendung zur Herstellung von Cycloheptimidazolderivaten Cycloheptenonderivate, a manufacturing method of these compounds and their use for the preparation of Cycloheptimidazolderivaten
12/14/2006	DE102005026809A1 Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzothiazol-2-one derivatives as inhibitors of lipases, and phospholipases
12/14/2006	DE102005026808A1 Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzooxazol-2-one derivatives as inhibitors of lipases, and phospholipases
12/14/2006	CA2614295A1 Transcription factor decoy
12/14/2006	CA2611451A1 Solid preparation

1 ... 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 ... 1595